Errol M. Rudman’s iShares Biotechnology ETF IBB Stock Holding History

Errol M. Rudman’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-35,000	Closed	-$4.27M	–	37
2018 Q3	$4.27M	Hold	35,000	–	–	1.59%	21
2018 Q2	$3.84M	Hold	35,000	–	–	1.79%	21
2018 Q1	$3.74M	Buy	35,000 +12,500	+56%	+$1.39M	1.79%	18
2017 Q4	$2.4M	Hold	22,500	–	–	1.16%	27
2017 Q3	$2.5M	Sell	22,500 -22,500	-50%	-$2.4M	1.44%	24
2017 Q2	$4.65M	Buy	+45,000	New	+$4.43M	2.34%	16
2016 Q3	–	Sell	-6,000	Closed	-$515K	–	27
2016 Q2	$515K	Buy	+6,000	New	+$538K	0.49%	18

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return

Errol M. Rudman's IBB Position: Q4 2018 in Review

Errol M. Rudman sold out of iShares Biotechnology ETF (IBB) in Q4 2018, closing a stake of 35,000 shares — an estimated $4.27M sold.

Errol M. Rudman first reported a position in IBB in Q2 2016 and held it in 7 quarters. The position peaked at $4.65M in Q2 2017. 649 funds tracked by Wall St. Rank hold IBB as of Q4 2018.

Errol M. Rudman reported no remaining iShares Biotechnology ETF position as of Q4 2018 after selling out during the quarter.
Errol M. Rudman sold 35,000 iShares Biotechnology ETF shares in Q4 2018, an estimated $4.27M.
Errol M. Rudman first reported a position in iShares Biotechnology ETF in Q2 2016 and held it in 7 quarters.
Errol M. Rudman's iShares Biotechnology ETF position peaked at $4.65M in Q2 2017.
649 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2018.

Based on Errol M. Rudman's 13F filing for Q4 2018, filed 14 Feb 2019.